接种SARS-CoV-2疫苗后的红斑狼疮

IF 1.1 Q4 ALLERGY

Journal of Cutaneous Immunology and Allergy Pub Date : 2023-10-03 DOI:10.1002/cia2.12326

Shumpei Kondo MD, Yasuaki Ogura MD, Masaki Ohtsuka MD, PhD, Yoshiki Tokura MD, PhD

{"title":"接种SARS-CoV-2疫苗后的红斑狼疮","authors":"Shumpei Kondo MD, Yasuaki Ogura MD, Masaki Ohtsuka MD, PhD, Yoshiki Tokura MD, PhD","doi":"10.1002/cia2.12326","DOIUrl":null,"url":null,"abstract":"<p>Pityriasis rubra pilaris (PRP) is a rare, chronic, inflammatory dermatosis characterized by follicular, hyperkeratotic papules and palmoplantar keratoderma at any age. The exact etiology of the disease remains unknown, but it can be triggered by multiple factors and genetic backgrounds. Here, we describe a case of PRP occurring after SARS-CoV-2 vaccination. While the vaccination is generally safe, it should be kept in mind that PRP may be evoked by SARS-CoV-2 vaccination for early recognition of the cause and prognosis of the patients.</p>","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12326","citationCount":"0","resultStr":"{\"title\":\"Pityriasis rubra pilaris following administration of SARS-CoV-2 vaccine\",\"authors\":\"Shumpei Kondo MD, Yasuaki Ogura MD, Masaki Ohtsuka MD, PhD, Yoshiki Tokura MD, PhD\",\"doi\":\"10.1002/cia2.12326\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Pityriasis rubra pilaris (PRP) is a rare, chronic, inflammatory dermatosis characterized by follicular, hyperkeratotic papules and palmoplantar keratoderma at any age. The exact etiology of the disease remains unknown, but it can be triggered by multiple factors and genetic backgrounds. Here, we describe a case of PRP occurring after SARS-CoV-2 vaccination. While the vaccination is generally safe, it should be kept in mind that PRP may be evoked by SARS-CoV-2 vaccination for early recognition of the cause and prognosis of the patients.</p>\",\"PeriodicalId\":15543,\"journal\":{\"name\":\"Journal of Cutaneous Immunology and Allergy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2023-10-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12326\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cutaneous Immunology and Allergy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cia2.12326\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cutaneous Immunology and Allergy","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cia2.12326","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

摘要

红斑性瘙痒症（PRP）是一种罕见的慢性炎症性皮肤病，其特征是任何年龄段均可出现毛囊性角化过度丘疹和掌跖角化症。该病的确切病因尚不清楚，但可由多种因素和遗传背景诱发。在此，我们描述了一例接种 SARS-CoV-2 疫苗后出现的 PRP。虽然接种疫苗总体上是安全的，但应牢记接种 SARS-CoV-2 疫苗可能会诱发 PRP，以便及早识别病因和预后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Pityriasis rubra pilaris following administration of SARS-CoV-2 vaccine

查看原文本刊更多论文

Pityriasis rubra pilaris following administration of SARS-CoV-2 vaccine

Pityriasis rubra pilaris (PRP) is a rare, chronic, inflammatory dermatosis characterized by follicular, hyperkeratotic papules and palmoplantar keratoderma at any age. The exact etiology of the disease remains unknown, but it can be triggered by multiple factors and genetic backgrounds. Here, we describe a case of PRP occurring after SARS-CoV-2 vaccination. While the vaccination is generally safe, it should be kept in mind that PRP may be evoked by SARS-CoV-2 vaccination for early recognition of the cause and prognosis of the patients.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Cutaneous Immunology and Allergy Medicine-Dermatology

CiteScore

0.60

自引率

10.00%

发文量

审稿时长

12 weeks